Co-Diagnostics Inc
NASDAQ:CODX

Watchlist Manager
Co-Diagnostics Inc Logo
Co-Diagnostics Inc
NASDAQ:CODX
Watchlist
Price: 2.34 USD -0.43% Market Closed
Market Cap: $4.9m

During the last 3 months Co-Diagnostics Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 80% over this period (open performance analysis).

The last transaction was made on Mar 20, 2023 by Brown Brian Lee , who bought 5.7k USD worth of CODX shares.

Last Transactions:
Brown Brian Lee
$+189.9
Durenard Eugene
$-700.5
Benson Reed L
$-3.1k
Egan Dwight H
$-13.9k
Serbin Richard S
$-3.4k
Durenard Eugene
$-3.5k
Nelson James B
$-4k
Serbin Richard S
$-5.7k
Durenard Eugene
$-3.4k
Benson Reed L
$-31.3k
Egan Dwight H
$-15.7k
Egan Dwight H
$-24.9k
Egan Dwight H
$-6.7k
Serbin Richard S
$-10.5k
Durenard Eugene
$-15.2k
Durenard Eugene
$-15.3k
Serbin Richard S
$-15.4k
Satterfield Brent
$+80.1
Satterfield Brent
$+32.5
Satterfield Brent
$+34.3
Satterfield Brent
$+33
Satterfield Brent
$+393.6k
View All Transactions

During the last 3 months Co-Diagnostics Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 80% over this period (open performance analysis).

The last transaction was made on Mar 20, 2023 by Brown Brian Lee , who bought 5.7k USD worth of CODX shares.

Sold
0-3
months
0 USD
0
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
No Insider Transactions
0
0 USD

Co-Diagnostics Inc
Insider Trading Chart

Co-Diagnostics Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Co-Diagnostics Inc
Last Insider Transactions

Global
Insiders Monitor

Co-Diagnostics Inc
Glance View

Market Cap
4.9m USD
Industry
Health Care

Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company is headquartered in Salt Lake City, Utah and currently employs 101 full-time employees. The company went IPO on 2017-07-12. The firm is engaged in developing, manufacturing and marketing diagnostics technology. Its reagents are used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules, such as deoxyribonucleic acid and ribonucleic acid. The company also sells diagnostic equipment from other manufacturers as self-contained lab systems (MDx device). The firm uses its proprietary test design system and proprietary reagents to design and sell polymerase chain reaction diagnostic tests for diseases and pathogens starting with tests for tuberculosis, a drug resistant tuberculosis test, hepatitis B and C, Malaria, dengue, human immunodeficiency virus and Zika virus, all of which tests have been designed and validated in its laboratory. Its diagnostics systems enable molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests.

CODX Intrinsic Value
3.21 USD
Undervaluation 27%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top